Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
3. Analysts differ on Abbott’s post-split prospects
Analysts on Wall Street are divided in their assessments of Abbott’s prospects after it spins out its branded pharmaceuticals business.
2. Medical device company M&A: Masimo no longer on the hunt for big deals
Masimo CEO Joe Kiani walks back from earlier comments that the Irvine, Calif.-based patient monitoring solutions company is looking to make a splash on the M&A front.
1. Medtronic analyzes CRM care in 9 emerging markets
Medtronic enrolls the 1st of thousands of patients in its IMPROVE Brady study, conducted in 9 emerging market countries and aimed at analyzing and potentially influencing diagnosis and treatment of patients with abnormal heart rhythms.
